Response to Gram-negative bacteria (GNB) is partially mediated by the recognition of GNB-derived endotoxin by host cells. Potent host response to endotoxin depends on the sequential interaction of endotoxin with lipopolysaccharide binding protein (LBP), CD14, MD-2 and TLR4. While CD14 facilitates the efficient transfer of endotoxin monomers to MD-2 and MD-2ÁTLR4, activation of MD-2ÁTLR4 can occur in the absence of CD14 through an unknown mechanism. Here, we show that incubation of purified endotoxin (E) aggregates (E agg , M r ! 20 million) in PBS with ! 0.1% albumin in the absence of divalent cations Ca 2+ and Mg 2+ , yields EÁalbumin complexes (M r $70,000). EÁalbumin transfers E monomers to sMD-2 or sMD-2ÁTLR4 ectodomain (TLR4 ecd ) with a 'K d ' of $4 nM and induces MD-2ÁTLR4-dependent, CD14-independent cell activation with a potency only 10-fold less than that of monomeric EÁCD14 complexes. Our findings demonstrate, for the first time, a mechanistic basis for delivery of endotoxin monomers to MD-2 and for activation of TLR4 that is independent of CD14.
Introduction
Infection by even small numbers of Gram-negative bacteria (GNB) typically elicits a rapid and robust innate immune response, characterized by the production of pro-inflammatory cytokines (e.g. TNF-a, IL-6) and the recruitment and activation of phagocytes at the site of infection. 1 Endotoxin [E, LPS, lipooligosaccharide (LOS)] is a unique, abundant glycolipid located in the outer leaflet of the outer membrane of GNB (GNB om ). 2 Potent host inflammatory responses to endotoxin are mediated by TLR4 and its obligatory co-receptor MD-2, which are expressed on the surface of multiple host cell types. 3, 4 While exposure to endotoxin facilitates the mobilization of the immune system against invading GNB, continued exposure to high concentrations of endotoxin, or the inability to resolve endotoxin-induced inflammation, can result in severe immunopathologies, such as sepsis. 5, 6 Potent host response to endotoxin involves the ordered interactions of endotoxin with lipopolysaccharide binding protein (LBP), membrane-bound CD14 (mCD14) or soluble CD14 (sCD14) and extracellular soluble MD-2 (sMD-2) or MD-2 bound to TLR4 (MD-2ÁTLR4). 3, [7] [8] [9] [10] [11] [12] [13] [14] LBP binds with high affinity to endotoxin-rich surfaces [e.g. GNB om , aggregates of purified endotoxin (E agg )], and likely alters the arrangement of endotoxin within this interface. 10, 15 It increases the exposure of the normally concealed hydrophobic lipid A moiety of endotoxin, catalyzing the extraction of individual endotoxin molecules by soluble or membrane associated CD14. [16] [17] [18] [19] This results in the formation of monomeric EÁCD14 7,10 which can then rapidly deliver the endotoxin monomer to sMD-2 or to MD-2ÁTLR4, which results in cellular activation. 8, 11, 12, 14, 20 While CD14 is required for maximal potency of response to endotoxin, activation of TLR4 by endotoxin can occur in the absence of CD14 through an unknown mechanism. [21] [22] [23] [24] Given what is known about the requirements for activation of MD-2ÁTLR4 by endotoxin, it is likely that a CD14-indepenent mechanism also requires the extraction and transfer of an endotoxin monomer from endotoxin-rich interfaces (e.g. GNB om , E agg ) to MD-2ÁTLR4. 8, 20, 25 This could involve an LBPindependent mechanism to destabilize packing of endotoxin monomers in endotoxin-rich surfaces and a host protein that, like CD14, acts as an endotoxin monomer acceptor/donor (i.e. 'CD14-surrogate'). This CD14surrogate would be capable of shuttling endotoxin monomers from disrupted interfaces to MD-2(ÁTLR4), thereby activating TLR4.
We now show that albumin can serve as a CD14 surrogate for delivery of endotoxin monomers to MD-2(ÁTLR4) and induces CD14-independent TLR4 activation. The rate-limiting step is extraction and transfer of endotoxin monomers from endotoxin-rich interfaces, as in the CD14-dependent pathway. Unlike CD14, transfer of endotoxin monomers to albumin is not promoted by LBP, but rather by depleting the divalent cations (Ca 2+ and Mg 2+ ) necessary to stabilize the dense packing of endotoxin monomers within endotoxin-enriched supramolecular assemblies. [26] [27] [28] These results provide new insights concerning the mechanism and molecular requirements of endotoxin recognition by MD-2ÁTLR4.
Materials and methods Materials
LBP and sCD14 were gifts from Xoma (Berkeley, CA, USA) and Amgen (Thousand Oaks, CA, USA) respectively. Acyloxyacyl hydrolase (AOAH) was a gift from Dr R. Munford (National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA). Human serum albumin (HSA) was obtained as an endotoxinfree 25% stock solution from Baxter Healthcare (Glendale, CA, USA). HEK293 cells stably expressing TLR4 (HEK TLR4) and their parental cell line (HEK293) were a gift from Dr J. Chow (Eisai Research Institute, Andover, MA, USA). L-929 cell conditioned medium was generated as previously described. 29 [ 3 H]Lipooligosaccharide (25,000 cpm/ pmol) was isolated from an aceE mutant of Neisseria meningitidis serogroup B after metabolic labeling as described previously. 30 [ 14 C ]Lipopolysaccharide, R c and S chemotypes, were isolated in the same way after metabolic labeling of aceE Escherichia coli CL99 (a galE mutant of E. coli O111:B4) during growth in medium supplemented with 1,2-[ 14 C]acetate AE 2 mM galactose (manuscript in preparation). 31 Chromatography matrices (Sephacryl HR S200 and Ni 2+ FF-sepharose) were purchased from GE Healthcare (Piscataway, NJ, USA). Anti-FLAG M2-agarose was purchased from Sigma (St Louis, MO, USA). Monoclonal Ab (mAb) specific for HSA (anti-HSA) [15C7] (ab10241) and control mouse IgG2b [MPC-11] (ab18469) were purchased from Abcam (Cambridge, UK).
Production of recombinant proteins
Recombinant human FLAG-TLR4 ectodomain was generated by transient transfection of HEK293T cells as previously described. 14 In brief, HEK293T cells were grown in DMEM supplemented with 10% fetal calf serum. Cells in T75 flasks ($80% confluent) were transfected with 12 mg of an expression vector containing cDNA encoding amino acids 24-631 of TLR4, corresponding to the predicted ectodomain of TLR4 (TLR4 ecd ) linked to a FLAG tag (pFLAG-CMV-TLR4 ecd ), using PolyFect reagent (Qiagen, Hilden, Germany). After 12 h, flasks were rinsed in PBS and 8 ml of serum-free medium (293 SFM, Invitrogen, Carlsbad, CA, USA) was added. Medium containing expressed protein was collected 24-48 h later. Medium was concentrated 10-20 fold using Millipore Centricon Plus-70 prior to use.
Recombinant human His 6 -MD-2 was generated as previously described. 15 Briefly, cDNA encoding MD-2 was inserted into pBAC3 (Novagen, Gibbstown, NJ, USA) to promote the secretion of MD-2 linked to a His 6 tag. The generated baculovirus was then amplified in Sf 9 cells and used to infect High Five TM (Invitrogen) insect cells in serum-free medium for protein production. Conditioned medium containing secreted His 6 -MD-2 was used to generate LOSÁMD-2 in co-capture experiments and bioassays. 
Preparation of [ 3 H]LOS agg and [ 3 H]LOSÁprotein complexes

Co-capture of [ 14 C]LOSÁalbumin with anti-HSA IgG
Mouse monoclonal anti-HSA (non-reactive with BSA) or isotype-matched control mouse IgG2b was coated on 96-well plates at a concentration of 30 mg/ml in 100 ml of 0.1 M sodium carbonate buffer (pH 9.5) by incubation for 18 h at 4 C with shaking. The buffered solution was then removed and the coated wells washed three times with PBS/0.05% Tween-20 (200 ml) followed by incubation for 2 h at 25 C with 100ml of 3nM [ 14 C]LOSÁalbumin or 3 nM [ 14 C]LOSÁMD-2 in PBS/ 1.0% BSA. After this incubation, the supernatant containing [ 3 H]LOSÁprotein complexes that did not bind to the Ab-coated well was removed from the well and transferred to additional Ab-coated wells to increase the anti-HSA mAb-dependent absorption of [ 3 H]LOSÁalbumin. This was repeated for a total of five incubations. After the final incubation, the supernatant was removed and 100 ml of aqueous 5% SDS solution was added to each of the washed wells that had been exposed to [ 15 Hence, the extent of partial deacylation of [ 3 H]LOS by AOAH was calculated as % of total cpm recovered in the ethanol-soluble fraction multiplied by three.
HEK293 activation assay
The HEK293 TLR4 cells or their parental cell line were seeded in a 96-well plate (1Â10 5 cells/well)in DMEM/ 10% FBS/ciprofloxacin (10 mg/ml) and incubated for 18 h at 37 C in 5% CO 2 and 95% humidity. The following day, cells were washed twice with warm PBS (pH 7.4) and the indicated treatments were added in 200 ml of DMEM/0.1% HSA. The cells were incubated with the indicated treatments for 18 h at 37 C. Activation of cells was assessed by measuring accumulation of extracellular IL-8 by ELISA (BD Biosciences, San Diego, CA, USA).
Alternatively, HEK293 TLR4 cells were seeded in a 96-well plate (5Â10 4 cells/well) in DMEM/10% FBS/ciprofloxacin (10 mg/ml) and incubated for 18 h at 37 C in 5% CO 2 and 95% humidity. The following day, the incubation medium was aspirated and cells were transfected with 0.5 mg/well of either empty vector (pCis-CK) or an MD-2 expression vector (MD-2-FLAG-His 6 ; pEF-BOS) with PolyFect reagent (Qiagen) per manufacturer's protocol. 32 The following day, the transfection medium was aspirated, 200 ml/well of fresh DMEM/10% FBS/ciprofoxacin was added and the cells were incubated for an additional 24 h to allow for maximal expression of plasmid products. The cells were then washed and treated as described above.
Preparation and activation of CD14KO bone marrow derived macrophages by LOS agg + LBP and LOSÁprotein complexes
Preparation of bone marrow derived macrophages (BMDM) was carried out as previously described. 29, 33 Briefly, tibias and femurs from C57BL/6 CD14KO mice were removed following isoflurane asphyxiation and cervical dislocation and the bones were flushed with DMEM using a 23-gauge needle. The flushed cells were grown on 100 Â 15 mm dishes in DMEM/10% heat-inactivated FBS/20% L-929 cell conditioned medium/ciprofloxacin (10 mg/ml) for 7 d at 37 C in 5% CO 2 . On day seven, growth medium was aspirated, cells were dislodged by incubation with versene, seeded in a 48-well plate (2.5 Â 10 5 cells/well) in DMEM/10% heat-inactivated FBS/ciprofloxacin (10 mg/ml), and incubated for 18 h at 37 C. The following day, cells were washed twice with warm PBS (pH 7.4) and incubated with the indicated treatments for 18 h at 37 C in DMEM/0.1% HSA. Activation of cells was assessed by measuring the accumulation of extracellular TNF by ELISA (BD Biosciences).
Reaction of His 6 -sMD-2 or His 6 -sMD-2/ FLAG-TLR4 ecd with either [ 3 H]LOSÁalbumin or [ 3 H]LOSÁsCD14 [ 3 H]LipooligosaccharideÁalbumin or [ 3 H]LOSÁsCD14
were incubated for 3 h at 37 C at the indicated concentrations with insect cell conditioned medium containing or lacking His 6 -sMD-2 (4 ml, 0.2 nM active protein), or a combination of 8 ml of insect cell medium containing MD-2 with 25 ml of HEK293 cell medium containing FLAG-TLR4 ecd (His 6 -sMD-2/FLAG-TLR4 ecd , 0.15 nM active complex) brought to 0.2 ml (His 6 -sMD-2 samples) or 0.4 ml (His 6 -sMD-2/FLAG-TLR4 ecd samples) with PBS (no Ca 2+ /Mg 2+ )/1.0% HSA, pH 7.4. Following this incubation, Ni 2+ FFsepharose beads (30 ml) to capture [ 3 H]LOSÁHis 6 -sMD-2 or anti-FLAG M2-agarose beads (30 ml) to capture [ 3 H]LOS-ÁHis 6 -sMD-2/FLAG-TLR4 ecd were added and incubated at 25 C with rotation for 45 min. Following this incubation, beads were spun-down via centrifugation at 1000 g for 2 min. The supernatant was collected and beads were washed twice in PBS (no Ca 2+ /Mg 2+ )/1.0% HSA, pH 7.4. The [ 3 H]LOS was quantified in the recovered supernatant, wash and beads via liquid scintillation spectroscopy. Radioactivity recovered in the beads was converted to molar amounts of product (i.e. [ 3 H]LOSÁMD-2 or ([ 3 H]LOSÁMD-2ÁTLR4 ecd ) 2 formed based on the known specific radioactivity of the [ 3 H]LOS. 14 Binding and Scatchard analyses were performed using Prism 5 (GraphPad, La Jolla, CA, USA) Software as described previously. 14 
Results
LBP/CD14-independent disaggregation of LOS agg and formation of LOSÁsMD-2 are promoted by limiting divalent cations (Ca 2+ /Mg 2+ )
The dense packing of endotoxin monomers within the GNB om or E agg depends on the presence of Ca 2+ and/or Mg 2+ to reduce electrostatic repulsion between neighboring polyanionic endotoxin molecules. [26] [27] [28] 34 Binding of these divalent cations to endotoxin can be reduced by either treatment of endotoxin-rich surfaces with Tris/ EDTA (pH 8.0) or by prolonged exposure to media depleted of these divalent cations. [35] [36] [37] We initially chose the latter conditions to determine whether limiting divalent cations could lead to LBP/CD14-independent disaggregation of purified high molecular mass LOS agg and the transfer of an endotoxin monomer to sMD-2. To facilitate quantitative analysis, we utilized uniformly radiolabeled [ 3 H]LOS (M r ! 20 million) sonicated for 15 min and then further incubated at 37 C in PBS AE Ca 2+ /Mg 2+ (see Materials and methods) and supplemented with 1.0% HSA. Size-exclusion (Sephacryl S200) chromatography was utilized to determine the aggregation state of the [ 3 H]LOS ( Figure 1A ). In the presence of divalent cations, nearly all of the [ 3 H]LOS eluted in the void volume (V 0 ), reflecting [ 3 H]LOS agg of M r > 250,000. However, in conditions of limiting Ca 2+ and Mg 2+ , more than half of the [ 3 H]LOS eluted later, at approximately the same elution volume as albumin alone ( Figure 1A) . Thus, conversion of the large [ 3 H]LOS agg (M r ! 20 million) to much smaller (M r $70,000) complexes was greatly enhanced by incubation in medium lacking Ca 2+ and Mg 2+ . Maximum conversion of the large LOS aggregates to M r $70,000 required incubations for up to 18 h ( Figure S1 ). All subsequent incubations intended to generate the M r $70,000 complex were therefore carried out for 18 h.
To test whether limiting divalent cations also promoted LBP/CD14-independent transfer of E monomers to sMD-2, [ 3 H]LOS was incubated with insect cell conditioned medium containing sMD-2 after pre-incubation of [ 3 H]LOS in PBS/1.0% HSA/ AE Ca 2+ and Mg 2+ . A new, later eluting (i.e. lower M r ) complex containing [ 3 H]LOS was formed to a much greater extent after the [ 3 H]LOS agg were pre-incubated in PBS without divalent cations ( Figure 1B ). This later eluting complex corresponded to monomeric [ 3 H]LOSÁMD-2 (M r $25,000) as determined by: 1) co-elution with purified LOSÁMD-2; 2) the absence of this complex when [ 3 H]LOS agg pre-incubated with PBS/1.0% HSA/AE Ca 2+ and Mg 2+ were incubated in control insect cell conditioned medium lacking sMD-2 ( Figure S2A) ; and, 3) dose-dependent activation of HEK TLR4 cells with potency equal to that of purified LOSÁMD-2 ( Figure S2B ). These data show that LOS agg are destabilized when divalent cations are limiting and can form smaller complexes similar in size to albumin. These smaller endotoxin-containing complexes are capable of delivering an endotoxin monomer to sMD-2, thus forming LOSÁMD-2.
LBP/CD14-independent disaggregation of LOS agg and formation of LOSÁMD-2 requires the presence of albumin
Albumin plays an essential role in LBP/CD14dependent activation of MD-2ÁTLR4 by facilitating LBP-catalyzed extraction and transfer of endotoxin monomers to CD14 from endotoxin-rich surfaces and the subsequent transfer of the endotoxin monomer from CD14 to sMD-2 or MD-2ÁTLR4. 10 To test whether albumin was necessary for the observed LBP/CD14independent disaggregation of LOS agg and formation of LOSÁMD-2, these experiments were repeated in the presence or absence of albumin ( Figure 1C Figure S1 ). Near maximal generation of the M r $70,000 complex was achieved with molar ratios of albumin to LOS as low as $1:1 after 18 h incubation at 37 C (data not shown). Aggregates of rough (R c chemotype) and smooth (S chemotype) LPS similarly generated a M r $70,000 complex under the above conditions ( Figure S3A, B) , which could react with sMD-2, independent of LBP/CD14, to form LPSÁMD-2 complexes ( Figure S3C ). Whereas LBP catalytically promotes the extraction and transfer of endotoxin monomers from endotoxin aggregates to CD14, the extraction and transfer of endotoxin monomers to albumin was not promoted by the presence of LBP ( Figure S4 ). 10, 15, 17 The M r˜7 0,000 complex is the donor of [ 3 
H]LOS monomers to sMD-2
To determine if the M r $70,000 complex could directly transfer endotoxin monomers to sMD-2, this complex was isolated by Sephacryl S200 chromatography after pre-incubation of [ 3 H]LOS agg in PBS/1.0% HSA (no Ca 2+ /Mg 2+ ). A longer (1.6 x 7.0 cm) S200 column was used to improve resolution of the M r $70,000 complex (second [ 3 H]LOS-containing peak) from the larger [ 3 H]LOS agg eluting in the V 0 (Figure 2A) . Pooled fractions from the up-and down-slopes of the first (Fx 53-59, corresponding to the V 0 ) and second (Fx 67-73) [ 3 H]LOS-containing peaks were re-analyzed by Sephacryl S200 chromatography to confirm the stability and enrichment of the larger [ 3 H]LOS agg in the V 0 and the M r $70,000 complex in the second peak ( Figure 2B) . These combined fractions were then incubated with sMD-2 at 37 C and the formation of monomeric [ 3 H]LOSÁMD-2 was evaluated by Sephacryl S200 chromatography ( Figure 2C ). Figure  2C ). Under these conditions, the M r $70,000 complex was the preferred donor of monomeric [ 3 H]LOS to sMD-2. The small amount of [ 3 H]LOSÁMD-2 formed when incubations were carried out with combined fractions 53-59 may reflect contaminating, incompletely resolved M r $70,000 complex ( Figure 2C ).
The M r˜7 0,000 complex contains E (LOS) monomer(s) complexed to albumin (LOSÁalbumin)
The dependence for generation of the M r $70,000 complex on the presence of albumin and the similar elution profile under size exclusion chromatography to that of albumin (Figure 2A, B ) strongly suggested that the M r $70,000 peak represents a complex of [ 3 H]LOS monomer(s) (M r $5000) and albumin (M r $ 65,000). To test this possibility more directly, the M r $70,000 complex was purified followed by assay of the ability of radiolabeled LOS in this complex to be captured by an immobilized anti-HSA mAb compared to an unrelated, isotype-matched mouse IgG2b. As shown in Figure 3 , the anti-HSA mAb captured nearly 40% of the radiolabeled LOS contained in the added M r $70,000 complex (i.e. pooled fractions of 67-73; Figure 2A ), while virtually no capture was seen in wells coated with control mouse IgG2b (Figure 3 ). There was no capture of [ 3 H]LOSÁMD-2 by immobilized anti-HSA (or by the control mouse IgG2b; Figure 3 ), further demonstrating the specificity of the co-capture by anti-HSA mAb of the radiolabeled LOS in the M r $70,000 complex.
The LOS in the M r˜7 0,000 complex (LOSÁalbumin) is susceptible to deacylation by AOAH 15 This may reflect increased accessibility of the lipid A fatty acyl chains to AOAH, a property which may favor endotoxin monomer transfer from one endotoxin binding protein to another. The ability of albumin to deliver an endotoxin monomer to MD-2 shown above ( Figure   2C ) indicates that endotoxin (LOS) is bound to albumin in a way that makes endotoxin monomer transfer possible and may, therefore, manifest increased susceptibility to AOAH. As previously shown, LOS within unmodified LOS aggregates are relatively refractory to AOAH (Figure 4 ) under physiologicbuffer conditions (see Materials and methods). 15 In contrast, LOS in the M r $70,000 complex (LOSÁalbumin), as in other complexes (e.g. LOS agg ÁLBP (200:1) and LOSÁCD14) that favor LOS monomer transfer, is much more susceptible to AOAH (Figure 4) . Note that the [ 3 H]LOS within the monomeric LOSÁMD-2 complex is also relatively insensitive to AOAH, paralleling the much less facile transfer of LOS from MD-2 and consistent with the sequestration of the acyloxyacyl-linked fatty acyl chains of endotoxin within the hydrophobic cavity of MD-2. 20,25
MD-2/TLR4 dependent, CD14-independent cell activation by LOSÁalbumin
The ability of LOSÁalbumin to deliver endotoxin (LOS) monomers to sMD-2 ( Figures 1 and 2) , generating bioactive LOSÁMD-2 ( Figure S2 ) strongly suggested that LOSÁalbumin complexes could provide a CD14-independent mechanism for cell activation. To test this hypothesis, we made use of HEK293 cells (which lack MD-2 and CD14) and tested the ability of LOSÁalbumin to activate HEK cells that stably express TLR4 (HEK TLR4) in the presence, or absence, of MD-2, monitoring secretion of IL-8 as an indicator of cell activation. Figure 5 shows that LOSÁalbumin induced robust activation of HEK TLR4 cells provided that MD-2 was also present, either as added sMD-2 in insect cell conditioned medium ( Figure 5B ) or by transient transfection of HEK TLR4 cells with an expression vector encoding MD-2 ( Figure 5A) . Little, or no, cell activation by LOSÁalbumin was observed toward either parental HEK293 cells lacking TLR4 regardless of whether sMD-2 was provided ( Figure 5B ) or HEK TLR4 cells without sMD-2 ('empty vector') or coexpressed MD-2 ( Figure 5A) . These findings demonstrate that LOSÁalbumin can activate cells that lack CD14 in an MD-2ÁTLR4-dependent manner.
Comparison of LOSÁalbumin vs. LOSÁsCD14 potency in MD-2ÁTLR4-dependent activation of HEK293 cells
The above findings indicate that LOSÁalbumin, much like monomeric LOSÁCD14 complexes, can induce MD-2ÁTLR4-dependent cell activation. 7, 8 To better gauge the relative potency of the LOSÁalbumin complexes, we directly compared the effects of increasing amounts of LOSÁalbumin vs. LOSÁsCD14 on the activation of HEK/TLR4 cells co-incubated with sMD-2 ( Figure 6A ) or co-expressing MD-2 ( Figure 6B ). Under these conditions, LOSÁalbumin was $10-fold less potent than LOSÁsCD14 in inducing MD-2ÁTLR4dependent cell activation (e.g. levels of IL-8 produced, respectively, by cells stimulated with 2 and 6 nM LOSÁalbumin were roughly equal to that induced by 200 and 600 pM LOSÁsCD14). In addition, BMDMs from CD14KO mice, which naturally express MD-2/ TLR4, were activated by LOSÁsCD14 and, to a similar extent, by a 10-fold higher concentration of LOSÁalbumin (Figure 7) . In contrast to LOSÁsCD14 or LOSÁalbumin, LOS agg + LBP induced little, or no, activation of either HEK 293 cells expressing MD-2 and TLR4 or CD14KO BMDMs (Figure 7) , paralleling the inability of LOS gg + LBP to efficiently transfer LOS monomers to MD-2 or MD-2ÁTLR4 in the absence of CD14. 8, 14 
Comparison of [ 3 H]LOSÁmonomer transfer from [ 3 H]LOSÁalbumin or [ 3 H]LOSÁsCD14 to sMD-2(ÁTLR4 ecd )
The lower potency of LOSÁalbumin vs. LOSÁsCD14 in inducing MD-2ÁTLR4-dependent cell activation ( Figure 6 ) could reflect lower efficiency (e.g. higher K d ) of transfer of LOS monomer from LOSÁalbumin vs. LOSÁsCD14 to sMD-2 and/or MD-2ÁTLR4. To test this hypothesis, we took advantage of our ability to sensitively, specifically and quantitatively measure LOS transfer from [ 3 H]LOSÁalbumin and from [ 3 H]LOSÁsCD14 to His 6 -sMD-2 and to His 6 -MD-2ÁFLAG-TLR4 ecd by co-capture assays utilizing Ni 2+ sepharose beads to capture complexes containing His 6 -MD-2 or anti-FLAG Ab-coated agarose beads to capture complexes containing FLAG-TLR4 ecd (Figure 8 ). 14, 32 Preliminary experiments demonstrated that the rate of [ 3 H]LOS transfer was slower from [ 3 H]LOSÁalbumin than from [ 3 H]LOSÁsCD14 ( Figure   S5 ). Therefore, the apparent 'K d ' of transfer was measured after 3 h incubation, a time sufficient for maximum transfer of LOS from both LOSÁalbumin and LOSÁsCD14 to sMD-2 and sMD-2ÁTLR4 ecd . Scatchard analysis indicated an apparent K 
Discussion
Previous work by our laboratory, and others, has shown that mammalian cell activation by endotoxin depends on the sequential interaction of endotoxin with specific host proteins and the delivery of endotoxin monomers to MD-2ÁTLR4. 3, 9, 14, 19, 38, 39 The best studied and most efficient of these mechanisms involves the formation of monomeric EÁCD14 complexes in a process dependent on the presence of LBP and albumin. 8 activation of TLR4 by endotoxin can occur in the absence of CD14. [21] [22] [23] [24] As activation of MD-2ÁTLR4 by endotoxin depends on the binding of a monomer of endotoxin to MD-2, this CD14-independent mechanism would still likely involve the alteration of endotoxinrich surfaces to favor the extraction and binding of an endotoxin monomer by a CD14-surrogate host protein, which would then transfer the monomeric endotoxin to MD-2(ÁTLR4). 3, 8, 11, 40, 41 Here we show, for the first time, a mechanistic basis for the activation of MD-2ÁTLR4 by endotoxin in the absence of CD14 and LBP utilizing apparently monomeric EÁalbumin complexes. It has been known for some time that albumin interacts with endotoxin, although the nature and physiologic consequences of these interactions have remained relatively uncharacterized. [42] [43] [44] [45] Studies investigating the physical and chemical determinants of endotoxin association with albumin have suggested that binding of endotoxin to albumin is primarily mediated by hydrophobic interactions of the fatty acyl chains of lipid A with one or more hydrophobic fatty acid binding sites within albumin. 42, 46 As such, the uptake of endotoxin by albumin may reflect albumin's role as a relatively nonspecific transporter of various hydrophobic molecules, rather than a specific and dedicated endotoxin carrier function. Fluorescent displacement assays utilizing dansylsarcosine and warfarin have suggested that the binding of lipid A by albumin occurs in domain III of the protein. 42 Domain III contains two high-affinity fatty acyl chain-binding pockets capable of accommodating long-chain (> 12 C) fatty acids. [47] [48] [49] [50] However, the mechanism by which albumin gained access to the fatty acids of lipid A, which are normally sequestered within the GNB om or within aggregates/micelles of purified lipid A (endotoxin), and the biologic properties of the resulting endotoxinÁalbumin complexes could not be elucidated from these earlier studies. 15, 17, 19, 28 We have now shown that the depletion or sequestration of the divalent cations necessary for the dense packing of the highly negatively charged endotoxin monomers within endotoxin-rich interfaces such as E agg (M r ! 20 million) favors the extraction and delivery of endotoxin to albumin and formation of stable EÁalbumin complexes (M r $70,000) (Figures 1 to 3) . Near maximal generation of the M r $70,000 EÁalbumin complex can occur with molar ratios of endotoxin to albumin approaching 1:1, suggesting that the M r $70,000 complex contains 1 mol of endotoxin (LOS, M r $5000) with 1 mol of albumin (M r $65,000). Importantly, EÁalbumin is capable of donating endotoxin to sMD-2 or MD-2 bound to TLR4, forming bioactive EÁMD-2(ÁTLR4) complexes (Figures 2 and S2) . Endotoxin bound to albumin is susceptible to partial deacylation by AOAH, as is endotoxin bound to CD14, suggesting the acyloxyacyl linkage of the branched fatty acids of the lipid A moiety of endotoxin is at least partially exposed to the aqueous environment when endotoxin is bound to either protein (Figure 4 ). 15 Partial exposure of lipid A acyl chains may be a necessary characteristic of endotoxin bound to proteins that promote the transfer of endotoxin monomers to downstream endotoxin binding proteins which substantially interact with the acyl chains of lipid A, such as MD-2. 15, 51 Indeed, like monomeric EÁsCD14, apparently monomeric EÁalbumin complexes are capable of activating cells that express TLR4 in the presence of sMD-2, or cells that express MD-2ÁTLR4, in an LBP/mCD14-independent manner ( Figure 5 ). 9 Taken together, these data show that albumin functions as a CD14-surrogate, binding endotoxin monomers released from endotoxin-rich interfaces and delivering those endotoxin monomers to MD-2(ÁTLR4), resulting in TLR4 activation.
Our cell activation data show that EÁalbumin is $10fold less potent in its ability to activate MD-2ÁTLR4 than EÁsCD14 ( Figure 6 ). This correlates with a $4-10-fold higher apparent K d of endotoxin transfer from EÁalbumin vs. EÁsCD14 to MD-2(ÁTLR4) and slower transfer kinetics of endotoxin monomers to MD-2(ÁTLR4) (Figure 8, S5 ). These differences may reflect more favorable endotoxin presentation by CD14 and/or a role for specific protein-protein (e.g. CD14-MD-2) contacts needed for initial docking of the endotoxin monomer donor to MD-2 and efficient endotoxin transfer. 8, [52] [53] [54] The differences ($10-fold) in the potency of MD-2ÁTLR4 activation by EÁalbumin vs. EÁsCD14 are not nearly as pronounced as differences ($1000-fold) previously observed in vitro and in vivo when comparing endotoxin potency in CD14-containing vs. CD14-free settings. 22, 23, 55 One possible explanation is that, in those earlier studies, the rate-limiting step in CD14independent pro-inflammatory action of endotoxin was the extraction and delivery of endotoxin monomers to albumin, rather than the activity of EÁalbumin per se. Our findings clearly show that neither albumin alone nor albumin in the presence of LBP promotes appreciable formation of bioactive monomeric EÁalbumin complexes ( Figure S4 ). Therefore, different biologic conditions may be required for the extraction and delivery of endotoxin monomers to albumin and subsequent E monomer delivery to MD-2 ( Figure 9 ). In our study, the transfer of endotoxin monomers to albumin was accomplished by manipulating the incubation media to deplete endotoxin-rich interfaces of stabilizing divalent cations. We speculate that similar disruption of endotoxin packing within the GNB om may be effected at extravascular neutrophil-rich infection sites where cationic antimicrobial proteins, such as bactericidal/permeability-increasing (BPI) protein, cathelicidins and defensins accumulate and target anionic groups in endotoxin that normally bind Ca 2+ and Mg 2+ . [56] [57] [58] [59] [60] [61] The interactions of these proteins with endotoxin may also reduce LBP-endotoxin interactions, inhibiting LBPdependent delivery of endotoxin to CD14 and thereby favoring transfer of endotoxin to albumin (which would be present in abundance). 62 The lower levels of plasma lipoproteins at extravascular (vs. intravascular) sites could favor delivery of endotoxin monomers to MD-2(TLR4) by reducing competing endotoxin binding reactions with lipoproteins. 63 This may be particularly important for EÁalbumin complexes, given the slower rate of transfer of E monomers from albumin (vs. CD14) to MD-2 ( Figure S5 ).
TLR4 is the only TLR capable of triggering two distinct intracellular signaling pathways: the MyD88dependent pathway, which utilizes the adaptor molecules MyD88 and Mal and results in production of pro-inflammatory cytokines, such as TNF; and the TRIF-dependent pathway, which signals through the adaptor molecules TRIF and TRAM and results in the production of type 1 interferons. [64] [65] [66] [67] The concerted action of these pathways helps produce an effective and appropriate immune response during most GNB infections. The mechanisms that govern the initiation and magnitude of activation of each TLR4 signaling pathway remain unclear. A role for CD14 in facilitating TRIF-dependent TLR4 signaling in response to endotoxin has been shown, but these observations have thus far been limited to macrophages from wt-and CD14null mice activated with a narrow range of endotoxin species (i.e. lipid A and Re LPS). 68 The ability of EÁalbumin to activate MD-2ÁTLR4 independently of CD14, combined with the capacity of EÁalbumin to bind both R and S species of endotoxin ( Figure S3 ) should provide a means for a more comprehensive analysis of mammalian host cell TLR4 activation by endotoxin in the absence of CD14 and the effects of this stimulation on subsequent activation of TRIF and/or MyD88-dependent signaling. Figure 9 . LBP/CD14-independent activation of host cells by EÁalbumin. Maximum potency of TLR4 activation occurs through the LBP/ CD14-dependent pathway (left) when LBP alters the dense packing of endotoxin within E agg and catalyzes the extraction of an endotoxin monomer by mCD14 or sCD14, which then transfers those monomers to MD-2(ÁTLR4). Alternatively, LBP/CD14-independent activation of host cells by endotoxin (right) can occur following destabilization of endotoxin aggregates by limiting or chelating divalent cations or perhaps by the action of host defense proteins, such as the complement membrane attack complex or host cationic antimicrobial peptides. This leads to the extraction and binding of endotoxin by albumin. Albumin can serve as a CD14-surrogate by transferring endotoxin monomers to MDÁ2(ÁTLR4), resulting in activation of TLR4. As activation of TLR4 by EÁalbumin occurs in the absence of CD14, it is possible that the resulting intracellular signaling would proceed predominantly through the MyD88-dependent pathway.
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